Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trialNicholas C. Turner, Alistair Ring, Richard D. Baird et al.|The Lancet Oncology|2020Cited by 351
Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statementSarah P. Blagden, A. Yiangou, Lucinda Billingham et al.|British Journal of Cancer|2020Cited by 44
Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspectiveSarah P. Blagden, Louise Brown, Stephanie Ellis et al.|British Journal of Cancer|2022Cited by 2